Cover Image

全球動物用疫苗市場:各動物疾病、技術、動物、地區 - 趨勢及預測

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2016-2021

出版商 Mordor Intelligence LLP 商品編碼 319396
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
全球動物用疫苗市場:各動物疾病、技術、動物、地區 - 趨勢及預測 Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2016-2021
出版日期: 2016年01月01日 內容資訊: 英文



第1章 簡介

第2章 市場分析

  • 動物醫療產品市場
  • 動物醫療和人類的醫療

第3章 市場趨勢

  • 推動市場的要素
    • 寵物擁有率的上升
    • 營養的改善
    • 消費者對食品安全的認知提高
    • 家畜生產的增加
    • 人畜共通感染疾病、經由食物傳染疾病
  • 阻礙市場的要素
    • 耕種地和水的不足
    • 耕地相關競爭激烈
    • 成本效益高的生產
  • 波特五力分析

第4章 全球動物用疫苗市場區隔:各動物、疾病

  • 寵物
  • 雞疫苗市場:各疾病
  • 豬疫苗市場:各疾病
  • 馬疫苗市場:各疾病
  • 全球動物用疫苗市場:各技術
    • 類毒素疫苗
    • 重組疫苗
    • 不活化疫苗
    • 弱毒化活病毒疫苗
  • 全球動物用疫苗市場:各地區
    • 北美
    • 歐洲
    • 亞太地區

第5章 競爭環境

  • 市場上主要加入企業
  • 合併、收購
  • 新產品上市
  • 協定、聯合、聯盟

第6章 企業簡介

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 附錄



The Global market for Veterinary Vaccines has been estimated at USD 12.12 billion in 2015and is projected to reach USD 20.81 billion by 2020at a CAGR of 9.42% during the forecast period from 2015 to 2020. Veterinary vaccines help to improve health and welfare of animals, increase production of livestock in a cost effective manner and prevent transmission of diseases among animals and also to humans. Efficient animal production and better access to high-quality protein dramatically increase meat and egg production and contribute to greater economic outcome. Also, rapid development of animal vaccines can play an effective role in controlling emerging diseases. Veterinary vaccines comprise only approximately 23% of the global market for animal health products.

Key factors like technological innovations, growing awareness of animal health, increasing investmentsby government bodies and associations are driving the market growth. In addition, increased demand for animal protein, including milk, meat, eggs and fish, increased expenditure on healthcare of companion animals.However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market.

The veterinary vaccines market is segmented on the basis of products, diseases, technologies and regions. Based on product type, the market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines and other animal vaccines. Porcine vaccines is the largest sub-segment contributing to major share of the market, whereas companion animal Vaccines is the fastest growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population. The technology segment includes live attenuated, inactivated, subunit, conjugate, toxoid, recombinant and DNA vaccines. Live attenuated vaccine technology is the major technology in the veterinary vaccines market. The disease type segment includes Rabies, Brucellosis, Leptospirosis, Influenza, Rift Valley fever, Newcastle disease, Nipah virus infection, Hendra virus infection, Porcine Reproductive and Respiratory Syndrome virus and Japanese encephalitis Q fever.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). European region is the leading veterinary vaccine market closely followed by United States. Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to growing demand for livestock, development of new products and favorable government initiatives.

Pfizer Animal Health, Merck Animal Health, Sanofi-Aventis Animal Health, Bayer Healthcare - Animal Health, Virbac, Novartis Animal Health, BoehringerIngelheim Animal Health and Heska Corporation are few of the key players for this market. The top 3 players in the Veterinary Vaccines market are Pfizer, Merck and Sanofi-Aventis, based on the revenues they generate each year. Pfizer is the market leader in the Veterinary vaccines market (by revenue) but Merck is the market leader in Livestock Vaccines market and Sanofi-Aventis is leading in the Companion Vaccines market. There have few Mergers/Acquisitions by the key players in the Veterinary Vaccines market to expand their product portfolio in order to top the global market. Ex: Pfizer acquiring Wyeth which supposedly the largest acquisition. The industry players have adopted certain growth strategies to excel in veterinary vaccines

Table of Contents


  • Study deliveratives
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and forecasr period years
  • General Study Assumptions


  • Introduction
  • Analysis Methodology
  • Econometric forecast models
  • Research Assumptions




  • Current market scenario
  • Technology Overview
  • New developments in therapeutics
  • Investment analysis
  • Porters Five Force Analysis
  • Bargaining Power of suppliers
  • Bargaining power of buyers
  • Degree of competition
  • Threat of substitution
  • Threat of new entrants


  • Market Drivers
  • Increase in pet ownership
  • Improved Nutrition
  • Intensifying consumer focus on food safety
  • Greater Livestock production
  • Increasing Zoonotic and Foodborne Diseases
  • Market Restraints
  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Cost effective production
  • Market Opportunities
  • Key Challenges
  • Global veterinary vaccine market Segmentation, By Type of Animals,based on diseases
  • Companion Animals
  • Disease mainly transferred by Saliva through Bites and Scratch
  • Capnocytophaga canimorsus
  • Pasteurella multocida
  • Cat scratch disease
  • Rabies
  • Enteric diseases with mainly faecal-oral transmittance
  • Salmonellosis
  • Camphylobacteriosis
  • Toxocarosis
  • Protozoans
  • Respiratory Tract Diseases
  • BRSV
  • Enzootic Bronchopneu
  • EVPC
  • IBR
  • Gastrointestinal Diseases
  • BVD/MD
  • Leptospirosis
  • Poultry Vaccines market , By diseases
  • Bronchitis
  • Avian Influenza
  • Marek's Disease
  • Newcastle Disease
  • Pig vaccines market, By disease
  • Porcine reproductive disease
  • Swine Influenza
  • Swine Pneumonia
  • Equine Vaccines market , By Disease
  • Encephalomyelitis
  • Rhinopneumonitis
  • Influenza (Horse Flu)
  • By Technology
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines (LAV)
  • Global veterinary vaccines market Segmentation, By Geography
  • Farm Animal Healthcare Market Financial Analytics Market, By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • Europe
  • France
  • UK
  • Germany
  • Italy
  • Spain and Portugal
  • Scandinavia
  • Asia-Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia and New Zealand
  • Rest of Asia Pacific
  • Middle East and Africa
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of Middle East and Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America


  • Mergers & Acquisitions
  • New Product Launches
  • Agreements, Collaborations & Partnerships


  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Ceva Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim
  • Analyst outlook for Investment Opportunities
  • Future outlook of market


  • Abbreviations
  • Bibliography
  • Disclaimer
Back to Top